AspirinPlacebo EffectDouble-Blind MethodPlacebosCross-Over StudiesTreatment OutcomeSingle-Blind MethodAnti-Inflammatory Agents, Non-SteroidalClinical Trials as TopicRandomized Controlled Trials as TopicAdministration, OralPain ManagementDrug Therapy, CombinationAcupuncture TherapyDose-Response Relationship, DrugNonprescription DrugsPain MeasurementPainPlatelet Aggregation InhibitorsRheumatologyTime FactorsBudesonideBlood PressureAdministration, InhalationRandom AllocationAnti-Inflammatory AgentsDrug Administration ScheduleHeart RateProspective StudiesAnalysis of VarianceAsthmaFollow-Up StudiesChronic DiseaseHypertensionForced Expiratory VolumePatient ComplianceResearch DesignPilot ProjectsRecurrenceSeverity of Illness IndexTiclopidineThromboxane B2Dietary SupplementsCyclooxygenase InhibitorsBlood GlucosePlatelet AggregationSalicylatesPlatelet Function TestsBlood PlateletsFibrinolytic AgentsHemorrhageSodium SalicylateIbuprofenAnticoagulantsTablets, Enteric-CoatedWarfarinAsthma, Aspirin-InducedGastrointestinal HemorrhageCyclooxygenase 1Bleeding TimeCyclooxygenase 2 InhibitorsAcetaminophenProstaglandin-Endoperoxide SynthasesThromboxanesPlatelet ActivationNaproxenMyocardial InfarctionThrombosisThromboxane A2Risk FactorsDipyridamoleDrug InteractionsStrokeDrug ResistanceIndomethacinLipoxinsGastric MucosaSulfinpyrazoneCyclooxygenase 2Stomach UlcerDelayed-Action PreparationsProstaglandinsDrug CombinationsCardiovascular DiseasesReye SyndromePrimary PreventionPremedicationSulfonamidesEpoprostenolDinoprostone